Infinity Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Infinity Pharmaceuticals regular Real Value cannot be determined due to lack of data. The prevalent price of Infinity Pharmaceuticals is $0.0. Our model calculates the value of Infinity Pharmaceuticals from evaluating the firm fundamentals such as Shares Outstanding of 90.76 M, return on asset of -0.61, and Return On Equity of -35.21 as well as inspecting its technical indicators and probability of bankruptcy.
Infinity Pharmaceuticals Total Value Analysis
Infinity Pharmaceuticals is currently forecasted to have valuation of (9.46 M) with market capitalization of 2.63 M, debt of 917 K, and cash on hands of 56.58 M. The negative valuation of Infinity Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Infinity Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(9.46 M) | 2.63 M | 917 K | 56.58 M |
Infinity Pharmaceuticals Investor Information
About 23.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.45. Infinity Pharmaceuticals had not issued any dividends in recent years. The entity had 1:4 split on the 13th of September 2006. Based on the key indicators related to Infinity Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Infinity Pharmaceuticals is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Infinity Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Infinity Pharmaceuticals has an asset utilization ratio of 6.15 percent. This signifies that the Company is making $0.0615 for each dollar of assets. An increasing asset utilization means that Infinity Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Infinity Pharmaceuticals Ownership Allocation
Infinity Pharmaceuticals has a total of 90.76 Million outstanding shares. Roughly 74.16 (percent) of Infinity Pharmaceuticals outstanding shares are held by general public with 2.36 % owned by insiders and only 23.48 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Infinity Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 2.59 M. Net Loss for the year was (44.37 M) with loss before overhead, payroll, taxes, and interest of (31.38 M).Infinity Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 89.2 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Infinity Stock
If you are still planning to invest in Infinity Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Infinity Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |